The race is on to develop a vaccine for the COVID-19 coronavirus. Australian researchers are leading several major clinical trials that might help bring an end to the deadly disease.
The Russian cyberthreat, now targeting coronavirus vaccine research, goes back over three decades, extends into the country’s educational systems and criminal worlds, and shows no signs of letting up.
For a COVID-19 vaccine to stop the pandemic, a large percentage of the population will have to get vaccinated. A law professor explains how far government and employer vaccine mandates can legally go.
The results from the phase 1 trial are a promising first step in showing that the mRNA vaccine is a viable candidate, but there are unanswered questions and it is still early in the process.
Vaccine development usually spans a number of decades. This is because there’s a need to understand the mechanisms of protection against the pathogen, and to minimise adverse reactions.
Word that the U.S. has bought up the entire supply of the COVID-19 drug remdesivir is another reminder that in a pandemic, treatments and vaccines need to be accessible to everyone, globally.
The smallpox vaccination used calf lymph, which was unacceptable to vegetarians and anti-vivisectionists who were growing in number from the mid 19th century.
A century ago, the influenza pandemic killed about 50 million people. Today we are battling the coronavirus pandemic. Are we any better off? Two social scientists share five reasons we have to be optimistic.
To find a SARS-CoV-2 vaccine, scientists need to work hands-on with the highly infectious coronavirus. It happens in a super secure lab designed to keep them safe and prevent any escapes.
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand